The 2023 Seasonal Flu Booster, COVID-19, and RSV Vaccines

As autumn approaches, the need to stay vigilant against respiratory illnesses like COVID-19, Influenza, and RSV (respiratory syncytial virus) remains critical. Fortunately, the U.S. Food and Drug Administration (FDA) and the CDC Advisory Committee on Immunization Practices (ACIP) have recently approved new vaccines to safeguard the U.S. population from these potentially deadly viral illnesses.

2023-09-15T16:12:59-05:00September 20, 2023|

Do You Really Need Both a Flu Shot and a COVID-19 Booster?

This year will mark the third flu season with COVID-19 still circulating. Both viruses can cause health problems ranging from mild symptoms to illnesses requiring hospitalization and medical support measures. Likewise, both illnesses can also be deadly for the most susceptible individuals, such as those with chronic health conditions or compromised immune systems. Learn how you can stay healthy.

2022-10-16T22:08:11-05:00October 19, 2022|

With Sharp Drop in Demand, Community-Based COVID-19 Testing Sites to End Operations March 31

The Illinois Department of Public Health (IDPH) announced today that in response to a sharp drop in the demand for COVID-19 testing services at the ten Community-Based Testing Sites and the anticipated end of federal funding, operations at the locations will end on March 31. IDPH previewed that operations would be winding down when the mask mandate was lifted and has seen traffic at the sites – which carried out more than 1.5 million tests in total throughout their operation – drop precipitously in recent weeks. The sites are currently handling less than one percent of the tests being conducted statewide.

2022-03-28T10:20:03-05:00March 28, 2022|

Illinois Department of Public Health Adds New COVID-19 Treatment for Distribution Across Illinois

As a new COVID-19 treatment rolls out across the country, the Illinois Department of Public Health (IDPH) continues to distribute these life-saving therapeutics equitably across the state.  On February 11, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for a new monoclonal antibody, bebtelovimab, for the treatment of COVID-19. 

2022-02-23T10:52:17-06:00February 23, 2022|

Gov. Pritzker Announces Illinois Plan to Lift Statewide Indoor Mask Requirement on Monday, February 28

With statewide COVID-19 hospitalization rates declining faster than any other point in the pandemic, Illinois is on track to lift the statewide indoor mask requirement on Monday, February 28, 2022. Mask requirements will continue where federally mandated, such as on public transit and in high-risk settings including healthcare facilities and congregate care.

2022-02-14T14:50:12-06:00February 14, 2022|
Go to Top